Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian A Walker

Showing results (21-30 of 137) with videos related to

Pageof 14
Sort By:
Otology & Neurotology Open|March 22, 2024
Incidence of Concomitant Semicircular Canal Dehiscence With OtosclerosisBrian A Walker, Ryan M Thorwarth, Lindsey L Stull, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 4, 2011
The dominantly expressed class I molecule of the chicken MHC is explained by coevolution with the polymorphic peptide transporter (TAP) genesBrian A Walker, Lawrence G Hunt, Anna K Sowa, et al.
Haematologica|November 16, 2016
Comprehensive translocation and clonality detection in lymphoproliferative disorders by next-generation sequencingDörte Wren, Brian A Walker, Monika Brüggemann, et al.
Pediatrics|December 5, 2006
Energy expenditure of sedentary screen time compared with active screen time for childrenLorraine Lanningham-Foster, Teresa B Jensen, Randal C Foster, et al.
Blood Cancer Journal|September 11, 2023
Identifying novel mechanisms of biallelic TP53 loss refines poor outcome for patients with multiple myelomaEnze Liu, Parvathi Sudha, Nathan Becker, et al.
BMC Bioinformatics|April 16, 2020
TarPan: an easily adaptable targeted sequencing panel viewer for research and clinical useCody Ashby, Michael Rutherford, Michael A Bauer, et al.
Haematologica|February 22, 2020
Differential RNA splicing as a potentially important driver mechanism in multiple myelomaMichael A Bauer, Cody Ashby, Christopher Wardell, et al.
Leukemia & Lymphoma|September 23, 2010
High expression levels of the mammalian target of rapamycin inhibitor DEPTOR are predictive of response to thalidomide in myelomaKevin D Boyd, Brian A Walker, Christopher P Wardell, et al.
Frontiers in Immunology|August 21, 2023
Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myelomaHong Phuong Nguyen, Anh Quynh Le, Enze Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2011
The reconstruction of transcriptional networks reveals critical genes with implications for clinical outcome of multiple myelomaLuca Agnelli, Mattia Forcato, Francesco Ferrari, et al.
Pageof 14

Showing results (21-30 of 137) with videos related to

Sort By:
Pageof 14
Otology & Neurotology Open|March 22, 2024
Incidence of Concomitant Semicircular Canal Dehiscence With OtosclerosisBrian A Walker, Ryan M Thorwarth, Lindsey L Stull, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 4, 2011
The dominantly expressed class I molecule of the chicken MHC is explained by coevolution with the polymorphic peptide transporter (TAP) genesBrian A Walker, Lawrence G Hunt, Anna K Sowa, et al.
Haematologica|November 16, 2016
Comprehensive translocation and clonality detection in lymphoproliferative disorders by next-generation sequencingDörte Wren, Brian A Walker, Monika Brüggemann, et al.
Pediatrics|December 5, 2006
Energy expenditure of sedentary screen time compared with active screen time for childrenLorraine Lanningham-Foster, Teresa B Jensen, Randal C Foster, et al.
Blood Cancer Journal|September 11, 2023
Identifying novel mechanisms of biallelic TP53 loss refines poor outcome for patients with multiple myelomaEnze Liu, Parvathi Sudha, Nathan Becker, et al.
BMC Bioinformatics|April 16, 2020
TarPan: an easily adaptable targeted sequencing panel viewer for research and clinical useCody Ashby, Michael Rutherford, Michael A Bauer, et al.
Haematologica|February 22, 2020
Differential RNA splicing as a potentially important driver mechanism in multiple myelomaMichael A Bauer, Cody Ashby, Christopher Wardell, et al.
Leukemia & Lymphoma|September 23, 2010
High expression levels of the mammalian target of rapamycin inhibitor DEPTOR are predictive of response to thalidomide in myelomaKevin D Boyd, Brian A Walker, Christopher P Wardell, et al.
Frontiers in Immunology|August 21, 2023
Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myelomaHong Phuong Nguyen, Anh Quynh Le, Enze Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2011
The reconstruction of transcriptional networks reveals critical genes with implications for clinical outcome of multiple myelomaLuca Agnelli, Mattia Forcato, Francesco Ferrari, et al.
Pageof 14